source
- Merck and Moderna cancer vaccine data leak shows modest benefit, shares slideA data leak ahead of the European Society of Medical Oncology meeting revealed early results for the personalized cancer vaccine intismeran autogene combined with Merck's Keytruda. The information…
- FDA accepts new submission for Biohaven’s Vyglxia, opening path to approvalBiohaven announced that the FDA has accepted a refreshed application for its rare disease drug Vyglxia, which targets a nerve‑damaging disorder. Vyglxia is being developed for spinocerebellar atax…